Steve Schonfeld’s Amedisys AMED Stock Holding History

Steve Schonfeld’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-12,600	Closed	-$1.16M	–	2014
2024 Q2	$1.16M	Buy	+12,600	New	+$1.17M	0.01%	1136

Other funds holding AMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Steve Schonfeld's AMED Position: Q2 2025 in Review

Steve Schonfeld sold out of Amedisys (AMED) in Q2 2025, closing a stake of 4,500 shares — an estimated $417K sold.

Steve Schonfeld first reported a position in AMED in Q4 2018 and held it in 14 quarters. The position peaked at $3.08M in Q3 2021. 320 funds tracked by Wall St. Rank hold AMED as of Q2 2025.

Steve Schonfeld reported no remaining Amedisys position as of Q2 2025 after selling out during the quarter.
Steve Schonfeld sold 4,500 Amedisys shares in Q2 2025, an estimated $417K.
Steve Schonfeld first reported a position in Amedisys in Q4 2018 and held it in 14 quarters.
Steve Schonfeld's Amedisys position peaked at $3.08M in Q3 2021.
320 funds tracked by Wall St. Rank held Amedisys as of Q2 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.